Brandon McMahon is a Hematology physician affiliated with University of Colorado Anschutz. OpenAlex indexes 87 publications with 2,302 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1665 Aurora Ct
Suite 2004
Aurora, CO 800452517
Telephone
720-848-0300Registry record last updated 16 Nov 2018.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year20241 payment
- GlaxoSmithKline, LLC.Program year20231 payment
- Alexion Pharmaceuticals, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
63.4%Antimetabolite22.6%Hydroxyurea100%Part D≥44 patientsKinase inhibitor19.3%Jakafi89%Ayvakit11%Part D<11 patients+ 5 more classes in this area
Blood & clotting
32.5%Factor Xa inhibitor18.8%Xarelto59%Eliquis41%Part D≥27 patientsVitamin K antagonist6.5%Warfarin Sodium100%Part D≥22 patients+ 3 more classes in this area
Respiratory
2.6%Opioid Agonist2.6%Hydrocodone-Acetaminophen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- TNF-α impairs platelet function by inhibiting autophagy and disrupting metabolism via syntaxin 17 downregulation
Journal of Clinical Investigation
2025 - NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024
Journal of the National Comprehensive Cancer Network
2024
Similar KOLs
Other experts from the same institution or the same specialty.
David Badesch, MD
University of Colorado Anschutz
Sarit Polsky, MD, MPH
University of Colorado Anschutz
Maria Nagel, MD
University of Colorado Anschutz
Tyler Buckner, MD
University of Colorado Anschutz
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”